-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BIl7LaTtpDzyu1IEFAfq5CUSU66ZSM1kpYr/+5dJTALMGg/WsXWySqEZEzRxgvAP Fu4VVtu7UuclPYH/n8Ibbw== 0000742112-06-000032.txt : 20061106 0000742112-06-000032.hdr.sgml : 20061106 20061106103936 ACCESSION NUMBER: 0000742112-06-000032 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20061106 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20061106 DATE AS OF CHANGE: 20061106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INVACARE CORP CENTRAL INDEX KEY: 0000742112 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 952680965 STATE OF INCORPORATION: OH FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-15103 FILM NUMBER: 061189011 BUSINESS ADDRESS: STREET 1: ONE INVACARE WAY STREET 2: P O BOX 4028 CITY: ELYRIA STATE: OH ZIP: 44036 BUSINESS PHONE: 4403296000 8-K 1 nov68k.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 6, 2006 INVACARE CORPORATION -------------------- (Exact Name of Registrant as Specified in its Charter) OHIO ---- (State or Other Jurisdiction of Incorporation) 0-12938 95-2680965 ------------------- ------------------- (Commission File No.) (IRS Employer Identification No.) One Invacare Way, P.O. Box 4028, Elyria, Ohio 44036 ---------------------------------------------------- (Address of Principal Executive Offices) (440) 329-6000 -------------- (Registrant's Telephone Number, Including Area Code) - -------------------------------------------------------------------------------- Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 204.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Item 7.01.Regulation FD Disclosure. On November 6, 2006, Invacare Corporation issued a press release regarding a final rule issued by the Centers for Medicare & Medicaid Services. The rule implements oxygen and capped rental provisions of the Deficit Reduction Act of 2005. The press release is furnished herewith as Exhibit 99.1. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Invacare Corporation By: /s/ Gregory C. Thompson --------------------------- Gregory C. Thompson Chief Financial Officer Date: November 6, 2006 EX-99 2 exhibit.txt EXHIBIT 99.1 Exhibit 99.1 Contact: Investor Inquiries Gregory C. Thompson 440-329-6111 Media Inquiries Lara L. Mahoney 440-329-6393 NEWS RELEASE CMS ANNOUNCES FINAL RULE TO IMPLEMENT DEFICIT REDUCTION ACT; ENCOURAGES THE USE OF NEW OXYGEN TECHNOLOGIES ELYRIA, Ohio (November 6, 2006) - On November 1, 2006, the Centers for Medicare & Medicaid Services (CMS) posted the final rule to implement oxygen and capped rental provisions of the Deficit Reduction Act of 2005 (DRA). The final rule encourages the use of new oxygen technologies like the Invacare(R) HomeFill(TM) Oxygen System. The final rule requires medical equipment providers to transfer title of oxygen equipment to the beneficiary after 36 months for equipment placed in service after January 2, 2006. CMS also established a payment class for new technology such as portable oxygen transfilling equipment and portable oxygen concentrators. This class, which includes the HomeFill Oxygen System, will receive higher payments than traditional portable modalities. "The final rule of the DRA is positive for the oxygen patients and the industry that serves them. CMS has confirmed the importance of new technology, and with the affirmation of the 36-month cap, providers have increased incentive to purchase our HomeFill Oxygen System. We're also pleased that CMS has given oxygen patients the freedom to switch to new technology, if they sign a patient consent form. CMS obviously wants to make it easier for patients to have access to the best technology available to them," said A. Malachi Mixon III, chairman and chief executive officer of Invacare. After the transfer of title to the patient, CMS will continue its policy of paying for "reasonable and necessary" maintenance and service of beneficiary owned equipment. Specifically, CMS will allow payments for general maintenance and servicing visits every six months beginning six months after ownership transfers to beneficiaries. Also, the provider who issued the equipment to the patient will be responsible for five years from the date of initial service to replace equipment that does not last for the reasonable useful lifetime established for the equipment under the Medicare program. "It is positive that CMS clarified how it will handle service of oxygen equipment when the title transfers to the patient. This also emphasizes the need for providers to invest in reliable and proven equipment in order to avoid servicing or replacing equipment after 36 months," continued Mixon. Invacare Corporation (NYSE: IVC), headquartered in Elyria, Ohio, is the global leader in the manufacture and distribution of innovative home and long-term care medical products that promote recovery and active lifestyles. The company has 5,900 associates and markets its products in 80 countries around the world. For more information about the company and its products, visit Invacare's website at www.invacare.com. ### -----END PRIVACY-ENHANCED MESSAGE-----